Serum fibrinogen is not elevated in patients with myasthenia gravis
Abstract Myasthenia gravis (MG) is an autoimmune, autoantibody-mediated disease characterized by fatigable weakness of skeletal muscles. MG is a heterogeneous disease that currently lacks a robust biomarker for diagnosing all subtypes. Residual serum fibrinogen was found to be elevated 1000-fold in...
Saved in:
| Main Authors: | Taylor A. Bauman, Sean M. Lee, Vern C. Juel, Yingkai Li, Karli Gilbert, Jiaxin Chen, Henry J. Kaminski, Linda L. Kusner, MGNet Investigators |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-97599-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current aspects of the clinic, diagnosis and treatment of acquired myasthenia gravis (review). Part 1: diagnostics
by: S. N. Bardakov, et al.
Published: (2016-06-01) -
Clinical characteristics and treatment outcomes of ocular myasthenia gravis at a tertiary eye care center in Eastern India
by: Thalluru Subhash, et al.
Published: (2025-06-01) -
The expectant management of a rare neonatal disease: transient neonatal myasthenia gravis
by: Farin Masra, et al.
Published: (2023-04-01) -
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis
by: Armando Martinez Salazar, et al.
Published: (2025-05-01) -
Subtype-specific atypical B cell profiles in myasthenia gravis reveal distinct immunopathological pathways
by: Patricia M. Sikorski, et al.
Published: (2025-06-01)